SCHEDULE: Bank of America Discloses 5.2% Stake in Outset Medical

Bank of America Corporation has reported a 5.2% beneficial ownership stake in medical technology company Outset Medical, Inc. as of December 31, 2025.

Summary

• Bank of America Corporation, through its various subsidiaries, beneficially owns 950,558 shares of Outset Medical, Inc. common stock.
• This ownership represents 5.2% of Outset Medical's outstanding common stock.
• The beneficial ownership calculation is based on 18,153,090 outstanding shares disclosed by Outset Medical in its Form 10-Q on November 10, 2025, as of November 6, 2025.
• Bank of America holds shared voting power over 950,501 shares and shared dispositive power over 950,549 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive disclosure. While a 13G is a routine regulatory filing, the significant stake held by a major financial institution like Bank of America can be interpreted as a positive signal of institutional confidence in Outset Medical.

Positives

• A significant institutional holding by Bank of America may signal confidence in Outset Medical's long-term prospects.
• The disclosure confirms that the stake is held in the ordinary course of business, not for activist purposes, which can provide stability.

Negatives

• This filing is a disclosure of an existing stake and does not inherently present negative operational or financial news for Outset Medical.

Risks

• The filing itself does not detail specific risks for Outset Medical, Inc. beyond the general market risks associated with holding common stock.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Outset Medical, Inc.'s future performance or Bank of America's investment strategy.

Industry Context

StockSavvy.ai notes that a 5.2% stake by a major financial institution like Bank of America in a medical technology company such as Outset Medical indicates significant institutional interest in the healthcare sector, particularly in innovative medical device companies. Such holdings can often be viewed as a vote of confidence in the company's market position and growth potential within its niche.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder like Bank of America may enhance investor confidence and potentially stabilize the stock price.
• Company Management: Awareness of a major institutional investor may influence strategic decisions, though Bank of America states its holding is not for control purposes.

Key Dates

Keywords

Outset Medical, Bank of America, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Medical Technology, Healthcare